Agilon Health (NYSE:AGL) Reaches New 12-Month High – Here’s What Happened

Agilon Health, Inc. (NYSE:AGL)’s stock price reached a new 52-week high during mid-day trading on Monday . The company traded as high as $119.07 and last traded at $114.2640, with a volume of 23927 shares trading hands. The stock had previously closed at $113.80.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. Wall Street Zen upgraded Agilon Health from a “sell” rating to a “hold” rating in a report on Saturday, May 9th. TD Cowen reiterated a “hold” rating and issued a $55.00 price objective (up from $17.00) on shares of Agilon Health in a research note on Monday, May 11th. Citigroup reissued a “neutral” rating and set a $80.00 price objective (up from $18.75) on shares of Agilon Health in a research report on Friday, May 15th. Weiss Ratings lowered shares of Agilon Health from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, May 27th. Finally, JPMorgan Chase & Co. cut shares of Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 target price on the stock. in a report on Monday, May 4th. Five research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $58.73.

Agilon Health Trading Up 1.3%

The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.08. The firm has a market cap of $1.92 billion, a PE ratio of -5.35 and a beta of 3.00. The business has a fifty day moving average price of $66.92 and a 200 day moving average price of $34.14.

Agilon Health (NYSE:AGL) last posted its earnings results on Wednesday, May 6th. The company reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.04 by $0.76. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%.The firm had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.38 billion. Analysts forecast that Agilon Health, Inc. will post -3.5 EPS for the current year.

Institutional Investors Weigh In On Agilon Health

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Wealthcare Advisory Partners LLC purchased a new stake in Agilon Health in the third quarter valued at $26,000. LPL Financial LLC increased its position in shares of Agilon Health by 213.4% during the fourth quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock worth $30,000 after purchasing an additional 30,000 shares in the last quarter. Krilogy Financial LLC acquired a new stake in shares of Agilon Health during the fourth quarter worth about $34,000. CIBC Bancorp USA Inc. purchased a new stake in shares of Agilon Health in the 3rd quarter valued at about $34,000. Finally, Merit Financial Group LLC purchased a new stake in shares of Agilon Health in the 4th quarter valued at about $35,000.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.